Tejnaksh Healthcare Faces Increased Bearish Outlook Amid Revenue Growth Challenges

Tejnaksh Healthcare, a microcap player in the healthcare services industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a mildly bearish stance to a more bearish outlook.
The stock's current price stands at 19.07, slightly below its previous close of 19.30. Over the past year, Tejnaksh Healthcare has faced challenges, with a notable return of -28.06%, significantly lagging behind the BSE500 benchmark. The company has also reported a -5.12% CAGR growth in net sales over the last five years, indicating persistent difficulties in maintaining revenue growth.

In terms of profitability, the average return on equity is recorded at 9.96%, suggesting limited efficiency in generating returns for shareholders. The most recent quarterly results showed a PBDIT of Rs 0.70 crore and a PBT of Rs 0.52 crore, both at their lowest levels. Despite these challenges, the stock is trading at a discount compared to its peers, with a price-to-book value of 1.5, which may indicate attractive valuation metrics.

For more insights on Tejnaksh Healthcare's performance and evaluation, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.